MAM
Tata Neu ropes in Akash Banerji as head of content & entertainment vertical
Mumbai: The Tata Group has roped in Akash Banerji to lead the content and entertainment vertical of Tata Neu app. Tata Digital unveiled its much-anticipated super app Tata Neu earlier this week.
In this role, Banerji will oversee the entire content vertical, including P&L, product, content creation, and marketing at Tata Neu, as per media reports.
Banerji was previously leading marketing for Amazon’s mobile business vertical, having joined the organisation in August 2020.
Prior to Amazon, he worked with Viacom18’s OTT platform Voot. He was with Viacom18 for five years.
Banerji has more than eighteen years of experience in the technology, marketing, sales/distribution & P&L domains with consumer centric MNCs.
He served in multiple industries across digital video (Hotstar & Voot), e-commerce (Prime), Slsports (Star Sports) & entertainment (Star Plus) broadcast & CPG (Pepsi, Marico).
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
